Inofolic
Natural health product licensed in Canada
- Licence holder
- BioSyent Pharma Inc.
- NPN or DIN-HM
- 80083082
- Status
- Active licence
- Licence date
- 13 February 2018
- Revision date
- 17 March 2026
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Myo-Inositol Source : Zea mays (Whole) | 600 milligramme | Not calculated |
| Folate Source : Acide folique | 200 microgrammes | Not calculated |
Non-medicinal ingredients
Oxydes de fer, Polyglyceryl-10 Oleate, Triglycérides à chaîne moyenne, Lécithine, Gélatine, Glycérine, Huile de soja, des mono- et diglycérides d'acides gras
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to support normal early fetal development. Helps to support early fetal development. Helps to reduce the risk of neural tube defects when taken daily at least three months prior to becoming pregnant and during early pregnancy. Helps promote regular ovulation in those with PCOS. Helps support regular menstrual cycles in those with PCOS Helps increase the quality of eggs released in each ovulatory cycle in those with PCOS. To help prepare for and support pregnancy in those with PCOS. Aids in the management of PCOS by reducing oxidative stresses. Aids in the management of polycystic ovarian syndrome (PCOS) by helping to restore normal ovarian function. Helps regularize menstrual cyclicity in those with PCOS. Helps to restore ovulation and oocyte quality and to normalize menstrual cycle irregularities. Aids in the management of PCOS's hormonal and metabolic conditions. Helps to reduce serum testosterone in women with PCOS. Helps reduce hyperandrogenism in PCOS women. Helps restore hormonal balance and ovulation in those with PCOS. Helps reduce hirsutism and acne in those with PCOS. Aids in the management of PCOS by promoting healthy glucose metabolism. Helps promote/restore pregnancy rates/fertility in women under 36 years old with PCOS who undergo in vitro fertilization (IVF). Helps to improve insulin sensitivity in women with PCOS. Helps reduce insulin resistance.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80083082
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.